Colistimethate (Paddock Laboratories, LLC)


Welcome to the PulseAid listing for the Colistimethate drug offered from Paddock Laboratories, LLC. This Polymyxin-class Antibacterial [EPC],Polymyxins [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Paddock Laboratories, LLC
NON-PROPRIETARY NAME: COLISTIMETHATE SODIUM
SUBSTANCE NAME: COLISTIMETHATE SODIUM
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Polymyxin-class Antibacterial [EPC],Polymyxins [Chemical/Ingredient]
ROUTE: INTRAMUSCULAR; INTRAVENOUS
DOSAGE FORM: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2014-04-15
END MARKETING DATE: 2018-06-30


Colistimethate HUMAN PRESCRIPTION DRUG Details:

Item DescriptionColistimethate from Paddock Laboratories, LLC
LABELER NAME: Paddock Laboratories, LLC
DEA SCHEDULE:
ACTIVE STRENGTH: 150(mg/2mL)
START MARKETING DATE: 2014-04-15
END MARKETING DATE: 2018-06-30
PRODUCT ID: 0574-0858_b74611e6-fdde-45a1-a535-f482a6fc9e3b
PRODUCT NDC: 0574-0858
APPLICATION NUMBER: ANDA065177

Other COLISTIMETHATE SODIUM Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Fresenius Kabi USA, LLCColistimethate
Heritage Pharmaceuticals Inc.COLISTIMETHATE SODIUM
Paddock Laboratories, LLCColistimethate
Par Pharmaceutical, Inc.Coly-Mycin
Sagent PharmaceuticalsColistimethate
X-GEN Pharmaceuticals, Inc.Colistimethate